Fetus of women with anti-SSA/Ro or/and anti-SSB /La antibodies have an approximate 2% risk of CHB [17, 19], and the risk approaches 19% if the woman has a history of a baby with neonatal lupus [20, 21]. The gene discussed is CALR; the disease is systemic lupus erythematosus.